Interpreting vitamin D assay results: proceed with caution.

Area of Science:

• Nephrology
• Clinical Chemistry
• Biomarker Analysis

Background:

• Vitamin D deficiency is prevalent in patients with chronic kidney disease (CKD), often linked to adverse health outcomes.
• Serum 25-hydroxyvitamin D (25-OH-D) is the primary biomarker for assessing vitamin D status.
• Current immunoassay methods for 25-OH-D measurement face accuracy and reproducibility challenges.

Purpose of the Study:

• To address the methodologic issues in serum 25-hydroxyvitamin D (25-OH-D) assays.
• To highlight the importance of accurate vitamin D testing in chronic kidney disease (CKD) management.
• To discuss the potential of emerging analytical methods for reliable vitamin D status assessment.

Main Methods:

• Review of existing literature and quality assessment programs (e.g., Vitamin D Standardization Program, DEQAS).
• Comparison of immunoassay-based methods with liquid chromatography-tandem mass spectrometry (LC-MS/MS).
• Analysis of assay performance for serum 25-OH-D measurement.

Main Results:

• Significant variability exists in the performance of current serum 25-OH-D assay methods.
• Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers enhanced accuracy and reliability compared to immunoassays.
• Standardization programs have aided in evaluating and improving assay performance.

Conclusions:

• Accurate measurement of serum 25-OH-D is vital for diagnosing vitamin D deficiency in CKD patients.
• Emerging LC-MS/MS methods promise more reliable vitamin D status assessment.
• Continued efforts in assay standardization are essential for effective patient monitoring and therapy.